Crispr Therapeutics shares tumble after significant earnings miss
NASHVILLE - FB Financial Corporation (NYSE:FBK) shares fell 7.5% after the parent company of FirstBank reported second-quarter revenue that significantly missed analyst expectations, despite posting adjusted earnings that met estimates.
The company reported adjusted earnings of $0.88 per share for the second quarter, matching analyst expectations. However, revenue came in at just $76.86 million, well below the consensus estimate of $136.37 million. The revenue shortfall occurred despite the company reporting loan growth and improved net interest margin.
FB Financial’s GAAP earnings were only $0.06 per share, with the difference primarily due to a $60.5 million loss from selling $266.5 million of low-yielding securities. The company indicated it plans to use proceeds from this transaction to redeem outstanding debt and originate higher-yielding loans.
"The Company delivered solid operating results in the second quarter with growth in both loans and customer deposits, a healthy net interest margin and managed expense growth," said Christopher T. Holmes, President and CEO.
Loans held for investment grew to $9.87 billion, up 6.07% from $9.31 billion in the same quarter last year. Total (EPA:TTEF) deposits increased 8.94% YoY to $11.40 billion. Net interest margin improved to 3.68% from 3.57% in the year-ago quarter.
The company’s core efficiency ratio improved to 56.9% compared to 58.3% in the second quarter of 2024. FB Financial maintained strong capital levels with a preliminary total risk-based capital ratio of 14.7%.
On July 1, FB Financial completed its merger with Southern States Bancshares, adding approximately $2.87 billion in total assets, $2.32 billion in loans, and $2.47 billion in deposits. The company expects system conversions related to the transaction to be completed in the third quarter.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.